Wednesday, January 29, 2014

Novartis Earnings Miss Forecasts

Swiss drug maker Novartis' fourth-quarter income rose 2% but sales of its newest products failed to offset a slowdown in an older drug.



from WSJ.com: US Business http://ift.tt/1e6qfxX

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)